Report Detail

Medical Devices & Consumables Global Insulin Needle-Free Injection Device Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4591839
  • |
  • 21 May, 2024
  • |
  • Global
  • |
  • 136 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Medical Devices & Consumables

An insulin needleless injection device is a medical device used to administer insulin therapy that allows patients to inject insulin through the surface of the skin without using a traditional injection needle. This device usually uses a special technology, such as a high-pressure gas or high-speed liquid jet, to spray a dose of insulin onto the surface of the skin, where it is then absorbed through the skin into the bloodstream.
According to our (Global Info Research) latest study, the global Insulin Needle-Free Injection Device market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Insulin Needle-Free Injection Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Insulin Needle-Free Injection Device market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2019-2030
Global Insulin Needle-Free Injection Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2019-2030
Global Insulin Needle-Free Injection Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2019-2030
Global Insulin Needle-Free Injection Device market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Insulin Needle-Free Injection Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Insulin Needle-Free Injection Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 3M, Bioject Medical Technologies, Eternity Healthcare, Crossject, National Medical Products, Valeritas, Neo Laboratories, PharmaJet, Medical International Technology, Bespak, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Insulin Needle-Free Injection Device market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Compressed
Liquid Jet
Market segment by Application
Hospital
Clinic
Rehabilitation Center
Others
Major players covered
3M
Bioject Medical Technologies
Eternity Healthcare
Crossject
National Medical Products
Valeritas
Neo Laboratories
PharmaJet
Medical International Technology
Bespak
Zogenix
Advantajet
InsuJet
Antares Pharma
D'Antonio Consultants International
PenJet Corporation
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Insulin Needle-Free Injection Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Insulin Needle-Free Injection Device, with price, sales quantity, revenue, and global market share of Insulin Needle-Free Injection Device from 2019 to 2024.
Chapter 3, the Insulin Needle-Free Injection Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Insulin Needle-Free Injection Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Insulin Needle-Free Injection Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Insulin Needle-Free Injection Device.
Chapter 14 and 15, to describe Insulin Needle-Free Injection Device sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Insulin Needle-Free Injection Device Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Compressed
    • 1.3.3 Liquid Jet
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Insulin Needle-Free Injection Device Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Rehabilitation Center
    • 1.4.5 Others
  • 1.5 Global Insulin Needle-Free Injection Device Market Size & Forecast
    • 1.5.1 Global Insulin Needle-Free Injection Device Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Insulin Needle-Free Injection Device Sales Quantity (2019-2030)
    • 1.5.3 Global Insulin Needle-Free Injection Device Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 3M
    • 2.1.1 3M Details
    • 2.1.2 3M Major Business
    • 2.1.3 3M Insulin Needle-Free Injection Device Product and Services
    • 2.1.4 3M Insulin Needle-Free Injection Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 3M Recent Developments/Updates
  • 2.2 Bioject Medical Technologies
    • 2.2.1 Bioject Medical Technologies Details
    • 2.2.2 Bioject Medical Technologies Major Business
    • 2.2.3 Bioject Medical Technologies Insulin Needle-Free Injection Device Product and Services
    • 2.2.4 Bioject Medical Technologies Insulin Needle-Free Injection Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Bioject Medical Technologies Recent Developments/Updates
  • 2.3 Eternity Healthcare
    • 2.3.1 Eternity Healthcare Details
    • 2.3.2 Eternity Healthcare Major Business
    • 2.3.3 Eternity Healthcare Insulin Needle-Free Injection Device Product and Services
    • 2.3.4 Eternity Healthcare Insulin Needle-Free Injection Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Eternity Healthcare Recent Developments/Updates
  • 2.4 Crossject
    • 2.4.1 Crossject Details
    • 2.4.2 Crossject Major Business
    • 2.4.3 Crossject Insulin Needle-Free Injection Device Product and Services
    • 2.4.4 Crossject Insulin Needle-Free Injection Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Crossject Recent Developments/Updates
  • 2.5 National Medical Products
    • 2.5.1 National Medical Products Details
    • 2.5.2 National Medical Products Major Business
    • 2.5.3 National Medical Products Insulin Needle-Free Injection Device Product and Services
    • 2.5.4 National Medical Products Insulin Needle-Free Injection Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 National Medical Products Recent Developments/Updates
  • 2.6 Valeritas
    • 2.6.1 Valeritas Details
    • 2.6.2 Valeritas Major Business
    • 2.6.3 Valeritas Insulin Needle-Free Injection Device Product and Services
    • 2.6.4 Valeritas Insulin Needle-Free Injection Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Valeritas Recent Developments/Updates
  • 2.7 Neo Laboratories
    • 2.7.1 Neo Laboratories Details
    • 2.7.2 Neo Laboratories Major Business
    • 2.7.3 Neo Laboratories Insulin Needle-Free Injection Device Product and Services
    • 2.7.4 Neo Laboratories Insulin Needle-Free Injection Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Neo Laboratories Recent Developments/Updates
  • 2.8 PharmaJet
    • 2.8.1 PharmaJet Details
    • 2.8.2 PharmaJet Major Business
    • 2.8.3 PharmaJet Insulin Needle-Free Injection Device Product and Services
    • 2.8.4 PharmaJet Insulin Needle-Free Injection Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 PharmaJet Recent Developments/Updates
  • 2.9 Medical International Technology
    • 2.9.1 Medical International Technology Details
    • 2.9.2 Medical International Technology Major Business
    • 2.9.3 Medical International Technology Insulin Needle-Free Injection Device Product and Services
    • 2.9.4 Medical International Technology Insulin Needle-Free Injection Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Medical International Technology Recent Developments/Updates
  • 2.10 Bespak
    • 2.10.1 Bespak Details
    • 2.10.2 Bespak Major Business
    • 2.10.3 Bespak Insulin Needle-Free Injection Device Product and Services
    • 2.10.4 Bespak Insulin Needle-Free Injection Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Bespak Recent Developments/Updates
  • 2.11 Zogenix
    • 2.11.1 Zogenix Details
    • 2.11.2 Zogenix Major Business
    • 2.11.3 Zogenix Insulin Needle-Free Injection Device Product and Services
    • 2.11.4 Zogenix Insulin Needle-Free Injection Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Zogenix Recent Developments/Updates
  • 2.12 Advantajet
    • 2.12.1 Advantajet Details
    • 2.12.2 Advantajet Major Business
    • 2.12.3 Advantajet Insulin Needle-Free Injection Device Product and Services
    • 2.12.4 Advantajet Insulin Needle-Free Injection Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Advantajet Recent Developments/Updates
  • 2.13 InsuJet
    • 2.13.1 InsuJet Details
    • 2.13.2 InsuJet Major Business
    • 2.13.3 InsuJet Insulin Needle-Free Injection Device Product and Services
    • 2.13.4 InsuJet Insulin Needle-Free Injection Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 InsuJet Recent Developments/Updates
  • 2.14 Antares Pharma
    • 2.14.1 Antares Pharma Details
    • 2.14.2 Antares Pharma Major Business
    • 2.14.3 Antares Pharma Insulin Needle-Free Injection Device Product and Services
    • 2.14.4 Antares Pharma Insulin Needle-Free Injection Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Antares Pharma Recent Developments/Updates
  • 2.15 D'Antonio Consultants International
    • 2.15.1 D'Antonio Consultants International Details
    • 2.15.2 D'Antonio Consultants International Major Business
    • 2.15.3 D'Antonio Consultants International Insulin Needle-Free Injection Device Product and Services
    • 2.15.4 D'Antonio Consultants International Insulin Needle-Free Injection Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 D'Antonio Consultants International Recent Developments/Updates
  • 2.16 PenJet Corporation
    • 2.16.1 PenJet Corporation Details
    • 2.16.2 PenJet Corporation Major Business
    • 2.16.3 PenJet Corporation Insulin Needle-Free Injection Device Product and Services
    • 2.16.4 PenJet Corporation Insulin Needle-Free Injection Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 PenJet Corporation Recent Developments/Updates

3 Competitive Environment: Insulin Needle-Free Injection Device by Manufacturer

  • 3.1 Global Insulin Needle-Free Injection Device Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Insulin Needle-Free Injection Device Revenue by Manufacturer (2019-2024)
  • 3.3 Global Insulin Needle-Free Injection Device Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Insulin Needle-Free Injection Device by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Insulin Needle-Free Injection Device Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Insulin Needle-Free Injection Device Manufacturer Market Share in 2023
  • 3.5 Insulin Needle-Free Injection Device Market: Overall Company Footprint Analysis
    • 3.5.1 Insulin Needle-Free Injection Device Market: Region Footprint
    • 3.5.2 Insulin Needle-Free Injection Device Market: Company Product Type Footprint
    • 3.5.3 Insulin Needle-Free Injection Device Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Insulin Needle-Free Injection Device Market Size by Region
    • 4.1.1 Global Insulin Needle-Free Injection Device Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Insulin Needle-Free Injection Device Consumption Value by Region (2019-2030)
    • 4.1.3 Global Insulin Needle-Free Injection Device Average Price by Region (2019-2030)
  • 4.2 North America Insulin Needle-Free Injection Device Consumption Value (2019-2030)
  • 4.3 Europe Insulin Needle-Free Injection Device Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Insulin Needle-Free Injection Device Consumption Value (2019-2030)
  • 4.5 South America Insulin Needle-Free Injection Device Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Insulin Needle-Free Injection Device Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Insulin Needle-Free Injection Device Sales Quantity by Type (2019-2030)
  • 5.2 Global Insulin Needle-Free Injection Device Consumption Value by Type (2019-2030)
  • 5.3 Global Insulin Needle-Free Injection Device Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Insulin Needle-Free Injection Device Sales Quantity by Application (2019-2030)
  • 6.2 Global Insulin Needle-Free Injection Device Consumption Value by Application (2019-2030)
  • 6.3 Global Insulin Needle-Free Injection Device Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Insulin Needle-Free Injection Device Sales Quantity by Type (2019-2030)
  • 7.2 North America Insulin Needle-Free Injection Device Sales Quantity by Application (2019-2030)
  • 7.3 North America Insulin Needle-Free Injection Device Market Size by Country
    • 7.3.1 North America Insulin Needle-Free Injection Device Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Insulin Needle-Free Injection Device Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Insulin Needle-Free Injection Device Sales Quantity by Type (2019-2030)
  • 8.2 Europe Insulin Needle-Free Injection Device Sales Quantity by Application (2019-2030)
  • 8.3 Europe Insulin Needle-Free Injection Device Market Size by Country
    • 8.3.1 Europe Insulin Needle-Free Injection Device Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Insulin Needle-Free Injection Device Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Insulin Needle-Free Injection Device Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Insulin Needle-Free Injection Device Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Insulin Needle-Free Injection Device Market Size by Region
    • 9.3.1 Asia-Pacific Insulin Needle-Free Injection Device Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Insulin Needle-Free Injection Device Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Insulin Needle-Free Injection Device Sales Quantity by Type (2019-2030)
  • 10.2 South America Insulin Needle-Free Injection Device Sales Quantity by Application (2019-2030)
  • 10.3 South America Insulin Needle-Free Injection Device Market Size by Country
    • 10.3.1 South America Insulin Needle-Free Injection Device Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Insulin Needle-Free Injection Device Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Insulin Needle-Free Injection Device Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Insulin Needle-Free Injection Device Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Insulin Needle-Free Injection Device Market Size by Country
    • 11.3.1 Middle East & Africa Insulin Needle-Free Injection Device Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Insulin Needle-Free Injection Device Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Insulin Needle-Free Injection Device Market Drivers
  • 12.2 Insulin Needle-Free Injection Device Market Restraints
  • 12.3 Insulin Needle-Free Injection Device Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Insulin Needle-Free Injection Device and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Insulin Needle-Free Injection Device
  • 13.3 Insulin Needle-Free Injection Device Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Insulin Needle-Free Injection Device Typical Distributors
  • 14.3 Insulin Needle-Free Injection Device Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Insulin Needle-Free Injection Device. Industry analysis & Market Report on Insulin Needle-Free Injection Device is a syndicated market report, published as Global Insulin Needle-Free Injection Device Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Insulin Needle-Free Injection Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report